- Home
- IMRN vs INBS Comparison
IMRN vs INBS Comparison
Compare IMRN & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- INBS
- Stock Information
- Founded
- IMRN 1994
- INBS 2016
- Country
- IMRN Australia
- INBS United States
- Employees
- IMRN N/A
- INBS N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- IMRN Health Care
- INBS Health Care
- Exchange
- IMRN Nasdaq
- INBS Nasdaq
- Market Cap
- IMRN 10.1M
- INBS 8.6M
- IPO Year
- IMRN N/A
- INBS N/A
- Fundamental
- Price
- IMRN $1.72
- INBS $1.23
- Analyst Decision
- IMRN Strong Buy
- INBS
- Analyst Count
- IMRN 1
- INBS 0
- Target Price
- IMRN $5.00
- INBS N/A
- AVG Volume (30 Days)
- IMRN 22.7K
- INBS 91.5K
- Earning Date
- IMRN 05-06-2025
- INBS 05-07-2025
- Dividend Yield
- IMRN N/A
- INBS N/A
- EPS Growth
- IMRN N/A
- INBS N/A
- EPS
- IMRN N/A
- INBS N/A
- Revenue
- IMRN $4,048,286.00
- INBS $3,031,405.00
- Revenue This Year
- IMRN N/A
- INBS $280.88
- Revenue Next Year
- IMRN N/A
- INBS $126.26
- P/E Ratio
- IMRN N/A
- INBS N/A
- Revenue Growth
- IMRN 82.90
- INBS 23.21
- 52 Week Low
- IMRN $1.60
- INBS $1.00
- 52 Week High
- IMRN $2.87
- INBS $3.04
- Technical
- Relative Strength Index (RSI)
- IMRN 46.67
- INBS 32.70
- Support Level
- IMRN $1.64
- INBS $1.34
- Resistance Level
- IMRN $1.91
- INBS $1.32
- Average True Range (ATR)
- IMRN 0.16
- INBS 0.10
- MACD
- IMRN 0.00
- INBS 0.02
- Stochastic Oscillator
- IMRN 31.00
- INBS 34.29
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).